Reena Salgia is a Gastroenterology physician affiliated with Henry Ford Hospital. OpenAlex indexes 123 publications with 2,861 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2799 W Grand Blvd
Detroit, MI 482022608
Telephone
313-916-8899Provider last certified this registry record 1 Nov 2023.
Clinical trials
- Radioembolization Versus External Radiation Therapy
Sponsor: Henry Ford Health System
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20253 payments
- Cook IncorporatedProgram year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
43.2%Bile Acid16.3%Ursodiol100%Part D≥52 patientsRifamycin Antibacterial10.5%Xifaxan100%Part D≥13 patients+ 3 more classes in this area
Cancer & immunology
30%Calcineurin inhibitor16.4%Tacrolimus71%Cyclosporine Modified29%Part D≥41 patientsKinase inhibitor8%Lenvima75%Everolimus25%Part D<11 patients+ 1 more class in this area
Cardiovascular
18.8%Aldosterone antagonist (MRA)8%Spironolactone100%Part D≥23 patientsLoop diuretic7.2%Furosemide100%Part D≥25 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study
The American Journal of Gastroenterology
2025 - Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma
Clinical Gastroenterology and Hepatology
2024 - S4522 A Case of Acute Budd Chiari Syndrome Treated With Portosystemic Shunting
The American Journal of Gastroenterology
2024 - Late Presentation of Recurrent Solid Pseudopapillary Pancreatic Neoplasm With Liver Metastases During Pregnancy
ACG Case Reports Journal
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Iltefat Hamzavi, MD
Henry Ford Hospital
Tamam Mohamad
Henry Ford Hospital
Kartik Gupta
Henry Ford Hospital
Ira Wollner, MD
Henry Ford Hospital
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”